familial partial lipodystrophy
MeSH: D052496ORPHA: 79083
Overview
lipodystrophy characterized by abnormal subcutaneous adipose tissue distribution beginning in late childhood or early adult life
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with familial partial lipodystrophy, sourced from HPO and Orphanet clinical annotations.
HypertensionInsulin resistanceLipoatrophyDiabetes mellitusInsulin-resistant diabetes mellitusXanthomatosisHypertriglyceridemiaHepatomegalyLoss of subcutaneous adipose tissue in limbsAplasia/Hypoplasia of the skinSecondary amenorrheaThin skinAtherosclerosisSkeletal muscle hypertrophyPolycystic ovariesLoss of facial adipose tissueOligomenorrheaAcanthosis nigricansHepatic steatosisCongestive heart failureHypertrophic cardiomyopathyCoronary artery atherosclerosisPancreatitisSplenomegalyHyperuricemiaGeneralized hirsutismMyopathyMyalgiaCalf muscle pseudohypertrophyAbnormality of skeletal muscle fiber sizeDysmenorrheaPrimary amenorrheaCirrhosisProminent veins on trunk
Classification & Codes
MeSH Code
D052496Orphanet Code
ORPHA:79083familial partial lipodystrophy
| MeSH | D052496 |
| Orphanet | ORPHA:79083 |
| Treatments | 0 drug(s) |
| Symptoms on record | 34 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO